Citizens Financial Group
ABCL icon

Citizens Financial Group’s AbCellera Biologics ABCL Stock Holding History

Citizens Financial Group’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.59M Sell
177,813
-34,077
-16% -$323K 0.03% 282
2026
Q2 		$1.66M Sell
211,890
-50,000
-19% -$244K 0.02% 333
2026
Q1 		$914K Hold
261,890
– – 0.01% 412
2025
Q4 		$896K Hold
261,890
– – 0.01% 421
2025
Q3 		$1.32M Buy
+261,890
New +$1.15M 0.02% 345
2024
Q4 		– Sell
-311,890
Closed -$811K – 579
2024
Q3 		$811K Hold
311,890
– – 0.02% 324
2024
Q2 		$923K Buy
+311,890
New +$1.18M 0.02% 280

Other funds holding ABCL

TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Guardian Partners
Guardian Partners Toronto, Canada $1.13B AUM 28.37% 1-Year Est. Return
Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return
DKM Wealth Management
DKM Wealth Management Stockton, California $158M AUM 11.62% 1-Year Est. Return
Lantern Wealth Advisors
Lantern Wealth Advisors Melville, New York $232M AUM 16.88% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Stone House Investment Management
Stone House Investment Management Tunkhannock, Pennsylvania $768M AUM 12.07% 1-Year Est. Return

Citizens Financial Group's ABCL Position: Q3 2026 in Review

Citizens Financial Group reduced its AbCellera Biologics (ABCL) stake by 16% in Q3 2026, selling an estimated $323K and leaving 177,813 shares worth $2.59M. The position accounts for 0.03% of the portfolio, ranked #282.

Citizens Financial Group first reported a position in ABCL in Q2 2024 and has held it in 7 quarters since. 15 funds tracked by Wall St. Rank hold ABCL as of Q3 2026.

  • Citizens Financial Group held 177,813 shares of AbCellera Biologics worth $2.59M as of Q3 2026.
  • Citizens Financial Group sold 34,077 AbCellera Biologics shares in Q3 2026, an estimated $323K.
  • AbCellera Biologics made up 0.03% of Citizens Financial Group's portfolio in Q3 2026, its #282 holding.
  • Citizens Financial Group first reported a position in AbCellera Biologics in Q2 2024 and has held it in 7 quarters since.
  • 15 funds tracked by Wall St. Rank held AbCellera Biologics as of Q3 2026.

Based on Citizens Financial Group's 13F filing for Q3 2026, filed 23 Oct 2026.